𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Postmenopausal Metastatic Breast Cancer

✍ Scribed by Laura Assersohn, Dr Stephen R.D. Johnston

Book ID
120840452
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Tongue
English
Weight
150 KB
Volume
2
Category
Article
ISSN
0099-7374

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metastatic male breast cancer
Metastatic male breast cancer
✍ Irina Khachaturyan πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 43 KB
Metastatic Breast Cancer Session
Metastatic Breast Cancer Session
✍ Fatima Cardoso; Eric Winer πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 36 KB
Preventable breast cancer is postmenopau
Preventable breast cancer is postmenopausal
✍ Kari Hemminki; Asta FΓΆrsti; Jan Sundquist; Seyed Mohsen Mousavi πŸ“‚ Article πŸ“… 2010 πŸ› Springer US 🌐 English βš– 385 KB
Pre- and postmenopausal breast cancer
Pre- and postmenopausal breast cancer
✍ G.Reza Najem; Benjamin F. Rush; Fred W. Miller; Paul E. Dimarco; Susan E. Roellk πŸ“‚ Article πŸ“… 1982 πŸ› Elsevier Science 🌐 English βš– 627 KB
Fadrozole hydrochloride in postmenopausa
Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma
✍ Antonius A. Miller; Allan Lipton; I. Craig Henderson; Rudolph Navari; Mary T. Mu πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 471 KB πŸ‘ 2 views

## BACKGROUND. Fadrozole hydrochloride (CGS-16949A) belongs to the class of aromatase inhibitors that lowers circulating estrogen levels by inhibiting the conversion of androgens to estrogens, thereby causing tumor regression in patients with breast carcinoma. METHODS. This was a prospective, ran